Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099). (Q54091129)

24 May 2018

title

Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099). (English)

1 reference

24 May 2018

0 references

1 reference

Russell JC

1

1 reference

24 May 2018

Graham SE

series ordinal

2

1 reference

24 May 2018

Dolphin PJ

series ordinal

3

1 reference

24 May 2018

publication date

1 June 1999

1 reference

24 May 2018

published in

Metabolism

1 reference

24 May 2018

volume

48

1 reference

24 May 2018

issue

6

1 reference

24 May 2018

page(s)

701-706

1 reference

24 May 2018

Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Myocardial and vascular lesions in the LA/N-corpulent rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Effects of chronic ethanol consumption in atherosclerosis-prone JCR:LA-corpulent rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Prevention of myocardial disease in JCR:LA-corpulent rats by running.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Improvement of insulin sensitivity and cardiovascular outcomes in the JCR:LA-cp rat by D-fenfluramine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by beta, beta'-tetramethylhexadecanedioic acid (MEDICA 16).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Cardioprotective and hypolipidemic effects of nisoldipine in the JCR:LA-cp rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Vasculopathy and insulin resistance in the JCR:LA-cp rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Effect of dietary n-3 fatty acids on atherosclerosis prone JCR:LA-corpulent rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Comparative determination of plasma cholesterol and triacylglycerol levels by automated gas--liquid chromatographic and autoanalyzer methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Rates of glucose utilization and glucogenesis in rats in the basal state induced by halothane anaesthesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Exaggerated stress-induced release of nonesterified fatty acids in JCR:LA-corpulent rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

The effects of low-dose BAY-m-1099 (Miglitol) on serum lipids and liver enzyme activity of obese and obese-diabetic corpulent rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

1-Deoxynojirimycin and related compounds inhibit glycogenolysis in the liver without affecting the concentration of phosphorylase a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

Beneficial effects of acarbose in the atherosclerosis-prone JCR:LA-corpulent rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990168-3

10.1016/S0026-0495(99)90168-3

7 January 2021

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

10381143

1 reference

24 May 2018